

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 6.19009362 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.75958308 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.63170954 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.52752706 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.41662218 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.38174464 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.32568189 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 5.32363029 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.30403858 |
| 10 | neural tube formation (GO:0001841) | 5.06736357 |
| 11 | regulation of synapse structural plasticity (GO:0051823) | 5.05838691 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.98570966 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.87105964 |
| 14 | glutamate secretion (GO:0014047) | 4.78270015 |
| 15 | protein localization to synapse (GO:0035418) | 4.76077063 |
| 16 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.72967291 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.61762387 |
| 18 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.58589383 |
| 19 | gamma-aminobutyric acid transport (GO:0015812) | 4.49619277 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.49404972 |
| 21 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.47903771 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.45162663 |
| 23 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.39206191 |
| 24 | striatum development (GO:0021756) | 4.34501904 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.33204271 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.31160518 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 4.31160518 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.31160518 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.31160518 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.31160518 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 4.31160518 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 4.29070274 |
| 33 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.27853632 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.25364852 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 4.24566088 |
| 36 | exploration behavior (GO:0035640) | 4.22214278 |
| 37 | proline transport (GO:0015824) | 4.18653136 |
| 38 | neuronal action potential propagation (GO:0019227) | 4.14967207 |
| 39 | neuron-neuron synaptic transmission (GO:0007270) | 4.07871178 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 4.06866034 |
| 41 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.98249135 |
| 42 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.98249135 |
| 43 | prepulse inhibition (GO:0060134) | 3.95409976 |
| 44 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.81051089 |
| 45 | positive regulation of neurotransmitter transport (GO:0051590) | 3.79261492 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.79260428 |
| 47 | positive regulation of membrane potential (GO:0045838) | 3.76625463 |
| 48 | neuron recognition (GO:0008038) | 3.75679048 |
| 49 | microglial cell activation (GO:0001774) | 3.75010727 |
| 50 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.74834368 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.74149482 |
| 52 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.72839578 |
| 53 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.72748543 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 3.72483004 |
| 55 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.70242952 |
| 56 | activation of protein kinase A activity (GO:0034199) | 3.68623753 |
| 57 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.66633349 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.66094963 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.63962699 |
| 60 | long-term memory (GO:0007616) | 3.62173703 |
| 61 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.61684538 |
| 62 | neurotransmitter transport (GO:0006836) | 3.60028916 |
| 63 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.59992380 |
| 64 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.58598132 |
| 65 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.56925899 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.55589129 |
| 67 | auditory behavior (GO:0031223) | 3.53686577 |
| 68 | positive regulation of synapse maturation (GO:0090129) | 3.52665355 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.52651360 |
| 70 | dopamine receptor signaling pathway (GO:0007212) | 3.47976238 |
| 71 | neuronal ion channel clustering (GO:0045161) | 3.46584164 |
| 72 | response to auditory stimulus (GO:0010996) | 3.43920589 |
| 73 | axonal fasciculation (GO:0007413) | 3.42350689 |
| 74 | negative regulation of dendrite development (GO:2000171) | 3.41926299 |
| 75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41809739 |
| 76 | long-term synaptic potentiation (GO:0060291) | 3.41689049 |
| 77 | response to histamine (GO:0034776) | 3.39202374 |
| 78 | behavioral response to nicotine (GO:0035095) | 3.38139358 |
| 79 | regulation of neurotransmitter levels (GO:0001505) | 3.38030731 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.37798330 |
| 81 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.37515771 |
| 82 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.37515771 |
| 83 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.37515771 |
| 84 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.34516613 |
| 85 | cell migration in hindbrain (GO:0021535) | 3.34440579 |
| 86 | regulation of neurotransmitter uptake (GO:0051580) | 3.33217387 |
| 87 | regulation of postsynaptic membrane potential (GO:0060078) | 3.32851342 |
| 88 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.32124386 |
| 89 | postsynaptic membrane organization (GO:0001941) | 3.31267048 |
| 90 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.30287626 |
| 91 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.29340322 |
| 92 | regulation of hippo signaling (GO:0035330) | 3.26826116 |
| 93 | behavioral response to cocaine (GO:0048148) | 3.26472418 |
| 94 | neuromuscular process controlling posture (GO:0050884) | 3.25378229 |
| 95 | regulation of female receptivity (GO:0045924) | 3.24877131 |
| 96 | learning (GO:0007612) | 3.21018181 |
| 97 | limb bud formation (GO:0060174) | 3.20933063 |
| 98 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.20648475 |
| 99 | regulation of gene silencing by miRNA (GO:0060964) | 3.20648475 |
| 100 | regulation of gene silencing by RNA (GO:0060966) | 3.20648475 |
| 101 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.20361147 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 3.20141249 |
| 103 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.19979546 |
| 104 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.19114643 |
| 105 | regulation of glutamate secretion (GO:0014048) | 3.17986065 |
| 106 | synapse assembly (GO:0007416) | 3.17601861 |
| 107 | membrane depolarization during action potential (GO:0086010) | 3.16165256 |
| 108 | pantothenate metabolic process (GO:0015939) | 3.15647455 |
| 109 | regulation of neurotransmitter secretion (GO:0046928) | 3.15447481 |
| 110 | glycine transport (GO:0015816) | 3.13139786 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 3.12655242 |
| 112 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.12166344 |
| 113 | neuromuscular process (GO:0050905) | 3.12081569 |
| 114 | fucose catabolic process (GO:0019317) | 3.11721237 |
| 115 | L-fucose metabolic process (GO:0042354) | 3.11721237 |
| 116 | L-fucose catabolic process (GO:0042355) | 3.11721237 |
| 117 | synaptic transmission, dopaminergic (GO:0001963) | 3.10476473 |
| 118 | behavioral defense response (GO:0002209) | 3.09686206 |
| 119 | behavioral fear response (GO:0001662) | 3.09686206 |
| 120 | epithelial cilium movement (GO:0003351) | 3.08754141 |
| 121 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.08086907 |
| 122 | social behavior (GO:0035176) | 3.07863675 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 3.07863675 |
| 124 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.07003409 |
| 125 | cilium movement (GO:0003341) | 3.06255628 |
| 126 | synaptic transmission (GO:0007268) | 3.05218739 |
| 127 | synaptic vesicle endocytosis (GO:0048488) | 3.03834600 |
| 128 | female mating behavior (GO:0060180) | 3.02389204 |
| 129 | membrane hyperpolarization (GO:0060081) | 3.02128493 |
| 130 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.02000644 |
| 131 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.01466005 |
| 132 | membrane depolarization (GO:0051899) | 3.01035820 |
| 133 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00416168 |
| 134 | regulation of protein kinase A signaling (GO:0010738) | 3.00122389 |
| 135 | negative regulation of interleukin-1 production (GO:0032692) | 2.99358341 |
| 136 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.95181068 |
| 137 | interkinetic nuclear migration (GO:0022027) | 2.94045231 |
| 138 | macrophage activation involved in immune response (GO:0002281) | 2.91829384 |
| 139 | response to host immune response (GO:0052572) | 2.91303992 |
| 140 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91303992 |
| 141 | macrophage activation (GO:0042116) | 2.90544234 |
| 142 | presynaptic membrane assembly (GO:0097105) | 2.86792627 |
| 143 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.85899975 |
| 144 | olfactory bulb development (GO:0021772) | 2.84217849 |
| 145 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.82481429 |
| 146 | establishment of protein localization to Golgi (GO:0072600) | 2.76681919 |
| 147 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.75672831 |
| 148 | nonmotile primary cilium assembly (GO:0035058) | 2.74558588 |
| 149 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.74246886 |
| 150 | response to host (GO:0075136) | 2.71233641 |
| 151 | response to host defenses (GO:0052200) | 2.71233641 |
| 152 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71233641 |
| 153 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.70394496 |
| 154 | negative regulation of B cell mediated immunity (GO:0002713) | 2.70394496 |
| 155 | histone-serine phosphorylation (GO:0035404) | 2.67550388 |
| 156 | superoxide anion generation (GO:0042554) | 2.58478330 |
| 157 | cell proliferation in forebrain (GO:0021846) | 2.58111669 |
| 158 | indolalkylamine metabolic process (GO:0006586) | 2.56787138 |
| 159 | kidney morphogenesis (GO:0060993) | 2.55553118 |
| 160 | retinal ganglion cell axon guidance (GO:0031290) | 2.55011948 |
| 161 | cilium organization (GO:0044782) | 2.54810718 |
| 162 | myeloid leukocyte mediated immunity (GO:0002444) | 2.53787349 |
| 163 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.52786321 |
| 164 | plasma membrane repair (GO:0001778) | 2.52403866 |
| 165 | neuronal stem cell maintenance (GO:0097150) | 2.52352868 |
| 166 | cilium morphogenesis (GO:0060271) | 2.52200564 |
| 167 | I-kappaB phosphorylation (GO:0007252) | 2.52099068 |
| 168 | histone mRNA catabolic process (GO:0071044) | 2.51739253 |
| 169 | lateral sprouting from an epithelium (GO:0060601) | 2.50994837 |
| 170 | embryonic epithelial tube formation (GO:0001838) | 2.49877561 |
| 171 | neutrophil activation (GO:0042119) | 2.49339730 |
| 172 | cellular extravasation (GO:0045123) | 2.47453298 |
| 173 | cilium assembly (GO:0042384) | 2.47402199 |
| 174 | positive regulation of action potential (GO:0045760) | 2.47370728 |
| 175 | protein targeting to Golgi (GO:0000042) | 2.47004594 |
| 176 | alkaloid metabolic process (GO:0009820) | 2.46752176 |
| 177 | detection of external biotic stimulus (GO:0098581) | 2.44865306 |
| 178 | epithelial tube formation (GO:0072175) | 2.44762271 |
| 179 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.44130278 |
| 180 | nucleus localization (GO:0051647) | 2.43997184 |
| 181 | cAMP catabolic process (GO:0006198) | 2.42782894 |
| 182 | axonemal dynein complex assembly (GO:0070286) | 2.42673556 |
| 183 | sulfation (GO:0051923) | 2.42649308 |
| 184 | tryptophan metabolic process (GO:0006568) | 2.42626724 |
| 185 | protein K11-linked deubiquitination (GO:0035871) | 2.40715504 |
| 186 | presynaptic membrane organization (GO:0097090) | 2.40618390 |
| 187 | response to pheromone (GO:0019236) | 2.39820411 |
| 188 | protein localization to cilium (GO:0061512) | 2.39560801 |
| 189 | regulation of sequestering of triglyceride (GO:0010889) | 2.36401008 |
| 190 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.35664157 |
| 191 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.35645571 |
| 192 | behavioral response to ethanol (GO:0048149) | 2.35014966 |
| 193 | adaptation of signaling pathway (GO:0023058) | 2.34610846 |
| 194 | kynurenine metabolic process (GO:0070189) | 2.34596586 |
| 195 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.33884082 |
| 196 | regulation of memory T cell differentiation (GO:0043380) | 2.33104552 |
| 197 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.33083939 |
| 198 | photoreceptor cell maintenance (GO:0045494) | 2.31257250 |
| 199 | indolalkylamine catabolic process (GO:0046218) | 2.30473579 |
| 200 | tryptophan catabolic process (GO:0006569) | 2.30473579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.86889425 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.99497864 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06433839 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95559272 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.86872555 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85698383 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75786195 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.74998706 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.72680587 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.72019779 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.57239190 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49495221 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48530329 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48530329 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48315718 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43441370 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.38891341 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35642633 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.35595076 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.32939628 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32067493 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31743562 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28867698 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28545974 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21565570 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.10247947 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07116985 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06868651 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.03412798 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02815355 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99085265 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94626937 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.91139388 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87692047 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85490489 |
| 36 | TP53_16413492_ChIP-PET_HCT116_Human | 1.82502461 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80483790 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.79791892 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76842652 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.70517107 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69765026 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.67564593 |
| 43 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67131091 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61705264 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59920880 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55966623 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53825518 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51672965 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.50778171 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49076220 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47185324 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44210377 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40534644 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.39716021 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38194833 |
| 56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.37791989 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36408764 |
| 58 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35613147 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.34396605 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33908362 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33385320 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33233086 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33020160 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.32825928 |
| 65 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29445559 |
| 66 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.28866469 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28214743 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25758995 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25742159 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24634770 |
| 71 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24508989 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24438024 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23279840 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23187793 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.21956156 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.21698783 |
| 77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20579579 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20509584 |
| 79 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.20293718 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19293783 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19197803 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19073667 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18584393 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18374662 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18374662 |
| 86 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17539640 |
| 87 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17028554 |
| 88 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16687431 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15944069 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15875798 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14872066 |
| 92 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14852418 |
| 93 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.13539803 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12997877 |
| 95 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09442295 |
| 96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09016879 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08878275 |
| 98 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08252127 |
| 99 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08250329 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07835958 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07687291 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07638570 |
| 103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06346182 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06334403 |
| 105 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06114331 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05823474 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05309803 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05195441 |
| 109 | JUN_21703547_ChIP-Seq_K562_Human | 1.04915053 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04687436 |
| 111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04355133 |
| 112 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03824457 |
| 113 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01312916 |
| 114 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00534544 |
| 115 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00434849 |
| 116 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00434849 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00243380 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99704174 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99529019 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99277424 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99212855 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99185064 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99185064 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99125621 |
| 125 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98971857 |
| 126 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98618191 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98099803 |
| 128 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97316003 |
| 129 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96626660 |
| 130 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.96404029 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96057982 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95156038 |
| 133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94819142 |
| 134 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94819142 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94506053 |
| 136 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93387098 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93064659 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92341668 |
| 139 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91997887 |
| 140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91610872 |
| 141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90684205 |
| 142 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88908061 |
| 143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88816351 |
| 144 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88202869 |
| 145 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86770476 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.01623156 |
| 2 | MP0002822_catalepsy | 5.55493546 |
| 3 | MP0003724_increased_susceptibility_to | 4.27114824 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.11735936 |
| 5 | MP0004270_analgesia | 3.87858058 |
| 6 | MP0003880_abnormal_central_pattern | 3.82920907 |
| 7 | MP0009046_muscle_twitch | 3.54191804 |
| 8 | MP0009745_abnormal_behavioral_response | 3.50448754 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.41829268 |
| 10 | MP0003136_yellow_coat_color | 3.39349144 |
| 11 | MP0000566_synostosis | 3.29709555 |
| 12 | MP0002064_seizures | 3.13262238 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.87526199 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.84283351 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.76707178 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.75990528 |
| 17 | MP0005248_abnormal_Harderian_gland | 2.65179629 |
| 18 | MP0001486_abnormal_startle_reflex | 2.64295229 |
| 19 | MP0002272_abnormal_nervous_system | 2.54512361 |
| 20 | MP0000427_abnormal_hair_cycle | 2.52126620 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.37311497 |
| 22 | MP0010030_abnormal_orbit_morphology | 2.29376918 |
| 23 | MP0002736_abnormal_nociception_after | 2.26508784 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.14234019 |
| 25 | MP0005646_abnormal_pituitary_gland | 2.11274702 |
| 26 | MP0003787_abnormal_imprinting | 2.11195619 |
| 27 | MP0000383_abnormal_hair_follicle | 2.10805588 |
| 28 | MP0005174_abnormal_tail_pigmentation | 2.10173908 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 2.10104367 |
| 30 | MP0002733_abnormal_thermal_nociception | 2.08538146 |
| 31 | MP0002277_abnormal_respiratory_mucosa | 2.07676650 |
| 32 | MP0001529_abnormal_vocalization | 2.01073094 |
| 33 | MP0001970_abnormal_pain_threshold | 1.97723357 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.88923253 |
| 35 | MP0004924_abnormal_behavior | 1.88923253 |
| 36 | MP0006292_abnormal_olfactory_placode | 1.87856492 |
| 37 | MP0005377_hearing/vestibular/ear_phenot | 1.83962501 |
| 38 | MP0003878_abnormal_ear_physiology | 1.83962501 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.82923892 |
| 40 | MP0003195_calcinosis | 1.82724620 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.80427623 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.78807224 |
| 43 | MP0002928_abnormal_bile_duct | 1.77689276 |
| 44 | MP0002557_abnormal_social/conspecific_i | 1.75346361 |
| 45 | MP0001984_abnormal_olfaction | 1.72151392 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.71295326 |
| 47 | MP0002184_abnormal_innervation | 1.70707577 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.70045940 |
| 49 | MP0004133_heterotaxia | 1.65222289 |
| 50 | MP0005171_absent_coat_pigmentation | 1.65123865 |
| 51 | MP0003879_abnormal_hair_cell | 1.62593181 |
| 52 | MP0000778_abnormal_nervous_system | 1.62420887 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.62351169 |
| 54 | MP0008569_lethality_at_weaning | 1.61436273 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.61077936 |
| 56 | MP0004130_abnormal_muscle_cell | 1.59604223 |
| 57 | MP0004381_abnormal_hair_follicle | 1.58737254 |
| 58 | MP0003045_fibrosis | 1.55312895 |
| 59 | MP0003329_amyloid_beta_deposits | 1.54017588 |
| 60 | MP0004484_altered_response_of | 1.53944694 |
| 61 | MP0004858_abnormal_nervous_system | 1.53605343 |
| 62 | MP0000955_abnormal_spinal_cord | 1.47701768 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.44558496 |
| 64 | MP0005253_abnormal_eye_physiology | 1.44421429 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.41205422 |
| 66 | MP0003122_maternal_imprinting | 1.40605936 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.38734621 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.37444984 |
| 69 | MP0002882_abnormal_neuron_morphology | 1.36663643 |
| 70 | MP0000579_abnormal_nail_morphology | 1.36583243 |
| 71 | MP0001324_abnormal_eye_pigmentation | 1.34451956 |
| 72 | MP0001293_anophthalmia | 1.33618705 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.33285860 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 1.33160123 |
| 75 | MP0008789_abnormal_olfactory_epithelium | 1.33042347 |
| 76 | MP0000647_abnormal_sebaceous_gland | 1.31772053 |
| 77 | MP0001188_hyperpigmentation | 1.26419324 |
| 78 | MP0002282_abnormal_trachea_morphology | 1.25381203 |
| 79 | MP0004142_abnormal_muscle_tone | 1.25052696 |
| 80 | MP0001905_abnormal_dopamine_level | 1.24548928 |
| 81 | MP0001286_abnormal_eye_development | 1.21912961 |
| 82 | MP0004885_abnormal_endolymph | 1.19936188 |
| 83 | MP0002095_abnormal_skin_pigmentation | 1.18647938 |
| 84 | MP0003252_abnormal_bile_duct | 1.14968345 |
| 85 | MP0000751_myopathy | 1.12640637 |
| 86 | MP0003011_delayed_dark_adaptation | 1.12062827 |
| 87 | MP0005195_abnormal_posterior_eye | 1.11082999 |
| 88 | MP0002152_abnormal_brain_morphology | 1.10824845 |
| 89 | MP0003633_abnormal_nervous_system | 1.10475356 |
| 90 | MP0000569_abnormal_digit_pigmentation | 1.08895999 |
| 91 | MP0009764_decreased_sensitivity_to | 1.08431086 |
| 92 | MP0002938_white_spotting | 1.07638145 |
| 93 | MP0002233_abnormal_nose_morphology | 1.07498166 |
| 94 | MP0001177_atelectasis | 1.02162336 |
| 95 | MP0004883_abnormal_blood_vessel | 1.01185108 |
| 96 | MP0000371_diluted_coat_color | 1.00823643 |
| 97 | MP0003631_nervous_system_phenotype | 0.99549328 |
| 98 | MP0002168_other_aberrant_phenotype | 0.98440944 |
| 99 | MP0008877_abnormal_DNA_methylation | 0.98057542 |
| 100 | MP0003119_abnormal_digestive_system | 0.97681379 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 0.97672882 |
| 102 | MP0003646_muscle_fatigue | 0.97382742 |
| 103 | MP0003828_pulmonary_edema | 0.97138697 |
| 104 | MP0000049_abnormal_middle_ear | 0.95518317 |
| 105 | MP0000631_abnormal_neuroendocrine_gland | 0.95064765 |
| 106 | MP0003283_abnormal_digestive_organ | 0.93642903 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.93294304 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.93043390 |
| 109 | MP0005499_abnormal_olfactory_system | 0.93043390 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.92340725 |
| 111 | MP0005164_abnormal_response_to | 0.90535161 |
| 112 | MP0005391_vision/eye_phenotype | 0.90397859 |
| 113 | MP0001502_abnormal_circadian_rhythm | 0.89025753 |
| 114 | MP0008872_abnormal_physiological_respon | 0.87436039 |
| 115 | MP0002229_neurodegeneration | 0.86706165 |
| 116 | MP0004085_abnormal_heartbeat | 0.86032596 |
| 117 | MP0008874_decreased_physiological_sensi | 0.85609298 |
| 118 | MP0003123_paternal_imprinting | 0.84956781 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.83289576 |
| 120 | MP0000026_abnormal_inner_ear | 0.81846114 |
| 121 | MP0003121_genomic_imprinting | 0.80006058 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 0.79470879 |
| 123 | MP0000428_abnormal_craniofacial_morphol | 0.79400322 |
| 124 | MP0002102_abnormal_ear_morphology | 0.78959245 |
| 125 | MP0000470_abnormal_stomach_morphology | 0.77919161 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.75519735 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.75430898 |
| 128 | MP0003938_abnormal_ear_development | 0.74827265 |
| 129 | MP0003632_abnormal_nervous_system | 0.73709084 |
| 130 | MP0002876_abnormal_thyroid_physiology | 0.73620051 |
| 131 | MP0004233_abnormal_muscle_weight | 0.72620769 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.72246127 |
| 133 | MP0005535_abnormal_body_temperature | 0.71345653 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.70878014 |
| 135 | MP0002752_abnormal_somatic_nervous | 0.70700766 |
| 136 | MP0002751_abnormal_autonomic_nervous | 0.69951365 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.68561754 |
| 138 | MP0002075_abnormal_coat/hair_pigmentati | 0.67446489 |
| 139 | MP0004145_abnormal_muscle_electrophysio | 0.66808855 |
| 140 | MP0005187_abnormal_penis_morphology | 0.66245555 |
| 141 | MP0003935_abnormal_craniofacial_develop | 0.65805199 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.65765358 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.65538022 |
| 144 | MP0003634_abnormal_glial_cell | 0.65510628 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.64187103 |
| 146 | MP0000465_gastrointestinal_hemorrhage | 0.63867166 |
| 147 | MP0008057_abnormal_DNA_replication | 0.63646653 |
| 148 | MP0002653_abnormal_ependyma_morphology | 0.63000446 |
| 149 | MP0003755_abnormal_palate_morphology | 0.62751849 |
| 150 | MP0003943_abnormal_hepatobiliary_system | 0.62411714 |
| 151 | MP0001986_abnormal_taste_sensitivity | 0.62304444 |
| 152 | MP0000604_amyloidosis | 0.61444942 |
| 153 | MP0001664_abnormal_digestion | 0.60596183 |
| 154 | MP0005409_darkened_coat_color | 0.59764078 |
| 155 | MP0001299_abnormal_eye_distance/ | 0.59061591 |
| 156 | MP0003861_abnormal_nervous_system | 0.58479870 |
| 157 | MP0005551_abnormal_eye_electrophysiolog | 0.57503575 |
| 158 | MP0001348_abnormal_lacrimal_gland | 0.56159646 |
| 159 | MP0010770_preweaning_lethality | 0.55068402 |
| 160 | MP0002082_postnatal_lethality | 0.55068402 |
| 161 | MP0010769_abnormal_survival | 0.54812804 |
| 162 | MP0002638_abnormal_pupillary_reflex | 0.54069227 |
| 163 | MP0001943_abnormal_respiration | 0.53043757 |
| 164 | MP0004215_abnormal_myocardial_fiber | 0.52991788 |
| 165 | MP0004742_abnormal_vestibular_system | 0.52890727 |
| 166 | MP0003690_abnormal_glial_cell | 0.52244749 |
| 167 | MP0010768_mortality/aging | 0.51252733 |
| 168 | MP0003956_abnormal_body_size | 0.50804060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.79941392 |
| 2 | Myokymia (HP:0002411) | 7.48342609 |
| 3 | Focal seizures (HP:0007359) | 5.49456724 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.44515046 |
| 5 | Visual hallucinations (HP:0002367) | 4.43704456 |
| 6 | Febrile seizures (HP:0002373) | 4.42797657 |
| 7 | Atonic seizures (HP:0010819) | 4.37089017 |
| 8 | Pancreatic cysts (HP:0001737) | 4.04655543 |
| 9 | Impaired vibration sensation in the lower limbs (HP:0002166) | 4.02294764 |
| 10 | Absence seizures (HP:0002121) | 3.88561119 |
| 11 | True hermaphroditism (HP:0010459) | 3.88084993 |
| 12 | Ankle clonus (HP:0011448) | 3.70283558 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.64204532 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.62183778 |
| 15 | Pancreatic fibrosis (HP:0100732) | 3.57555429 |
| 16 | Dialeptic seizures (HP:0011146) | 3.44792097 |
| 17 | Broad-based gait (HP:0002136) | 3.42049664 |
| 18 | Abnormal social behavior (HP:0012433) | 3.41777946 |
| 19 | Impaired social interactions (HP:0000735) | 3.41777946 |
| 20 | Poor eye contact (HP:0000817) | 3.36547155 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.31399622 |
| 22 | Action tremor (HP:0002345) | 3.26857839 |
| 23 | Hyperventilation (HP:0002883) | 3.26295956 |
| 24 | Absent/shortened dynein arms (HP:0200106) | 3.13055093 |
| 25 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.13055093 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.12261613 |
| 27 | Dysdiadochokinesis (HP:0002075) | 3.08287134 |
| 28 | Resting tremor (HP:0002322) | 3.05471490 |
| 29 | Torticollis (HP:0000473) | 3.03729475 |
| 30 | Esophageal atresia (HP:0002032) | 3.00453186 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 2.99025181 |
| 32 | Abnormal ciliary motility (HP:0012262) | 2.98995660 |
| 33 | Mutism (HP:0002300) | 2.97568133 |
| 34 | Stomach cancer (HP:0012126) | 2.92807284 |
| 35 | Progressive inability to walk (HP:0002505) | 2.90467968 |
| 36 | Depression (HP:0000716) | 2.88919757 |
| 37 | Optic neuritis (HP:0100653) | 2.84713775 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.84713775 |
| 39 | Dysmetria (HP:0001310) | 2.82743398 |
| 40 | Fetal akinesia sequence (HP:0001989) | 2.81920282 |
| 41 | Polyphagia (HP:0002591) | 2.81532642 |
| 42 | Urinary urgency (HP:0000012) | 2.80125531 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.79507574 |
| 44 | Truncal ataxia (HP:0002078) | 2.79164158 |
| 45 | Anxiety (HP:0000739) | 2.78722437 |
| 46 | Orchitis (HP:0100796) | 2.78371641 |
| 47 | Nephronophthisis (HP:0000090) | 2.77589437 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.74639893 |
| 49 | Abnormality of midbrain morphology (HP:0002418) | 2.74639893 |
| 50 | Abnormality of the renal medulla (HP:0100957) | 2.74117599 |
| 51 | Type II lissencephaly (HP:0007260) | 2.72739767 |
| 52 | Papilledema (HP:0001085) | 2.71215947 |
| 53 | Focal dystonia (HP:0004373) | 2.69906722 |
| 54 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.69126519 |
| 55 | Short 4th metacarpal (HP:0010044) | 2.69126519 |
| 56 | Spastic gait (HP:0002064) | 2.68079703 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.66593956 |
| 58 | Diplopia (HP:0000651) | 2.66593956 |
| 59 | Impaired vibratory sensation (HP:0002495) | 2.66355631 |
| 60 | Gait imbalance (HP:0002141) | 2.65334341 |
| 61 | Pheochromocytoma (HP:0002666) | 2.63748465 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.60300662 |
| 63 | Epileptiform EEG discharges (HP:0011182) | 2.59269611 |
| 64 | Cystic liver disease (HP:0006706) | 2.59066815 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.57099855 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.56418378 |
| 67 | Hypsarrhythmia (HP:0002521) | 2.54977372 |
| 68 | Postural instability (HP:0002172) | 2.54592913 |
| 69 | Drooling (HP:0002307) | 2.53762341 |
| 70 | Excessive salivation (HP:0003781) | 2.53762341 |
| 71 | Craniofacial dystonia (HP:0012179) | 2.51625434 |
| 72 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.51255703 |
| 73 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.51255703 |
| 74 | Pendular nystagmus (HP:0012043) | 2.49917793 |
| 75 | Congenital stationary night blindness (HP:0007642) | 2.49366295 |
| 76 | Limb dystonia (HP:0002451) | 2.48462342 |
| 77 | Termporal pattern (HP:0011008) | 2.48029811 |
| 78 | Insidious onset (HP:0003587) | 2.48029811 |
| 79 | Scanning speech (HP:0002168) | 2.47574269 |
| 80 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47369598 |
| 81 | Genetic anticipation (HP:0003743) | 2.46585339 |
| 82 | Myositis (HP:0100614) | 2.46326882 |
| 83 | Gastrointestinal atresia (HP:0002589) | 2.43349466 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.42372462 |
| 85 | Abnormality of the labia minora (HP:0012880) | 2.41575318 |
| 86 | Annular pancreas (HP:0001734) | 2.40818461 |
| 87 | Chronic hepatic failure (HP:0100626) | 2.36110632 |
| 88 | Aqueductal stenosis (HP:0002410) | 2.35925318 |
| 89 | Stomatitis (HP:0010280) | 2.35659681 |
| 90 | Anophthalmia (HP:0000528) | 2.35644860 |
| 91 | Akinesia (HP:0002304) | 2.35364829 |
| 92 | Abnormality of the renal cortex (HP:0011035) | 2.29362764 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 2.26387565 |
| 94 | Attenuation of retinal blood vessels (HP:0007843) | 2.25554651 |
| 95 | Stereotypic behavior (HP:0000733) | 2.24855958 |
| 96 | Bradykinesia (HP:0002067) | 2.24290991 |
| 97 | Inability to walk (HP:0002540) | 2.24180411 |
| 98 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.22571792 |
| 99 | Neuroendocrine neoplasm (HP:0100634) | 2.21722427 |
| 100 | Poor suck (HP:0002033) | 2.21456509 |
| 101 | Specific learning disability (HP:0001328) | 2.21295885 |
| 102 | Dysmetric saccades (HP:0000641) | 2.19858232 |
| 103 | Amblyopia (HP:0000646) | 2.19464844 |
| 104 | Lower limb muscle weakness (HP:0007340) | 2.16363328 |
| 105 | Hypoplastic labia majora (HP:0000059) | 2.16108217 |
| 106 | Decreased central vision (HP:0007663) | 2.15260919 |
| 107 | Protruding tongue (HP:0010808) | 2.14422934 |
| 108 | Subacute progressive viral hepatitis (HP:0006572) | 2.13640430 |
| 109 | Generalized myoclonic seizures (HP:0002123) | 2.13593402 |
| 110 | Anencephaly (HP:0002323) | 2.12819038 |
| 111 | Impaired smooth pursuit (HP:0007772) | 2.12433054 |
| 112 | Hemiplegia (HP:0002301) | 2.11357577 |
| 113 | Sclerocornea (HP:0000647) | 2.10841573 |
| 114 | Widely spaced teeth (HP:0000687) | 2.10768544 |
| 115 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.09705459 |
| 116 | Keratoconjunctivitis (HP:0001096) | 2.09363927 |
| 117 | Congenital primary aphakia (HP:0007707) | 2.09069469 |
| 118 | Abnormality of incisor morphology (HP:0011063) | 2.09067053 |
| 119 | Arthropathy (HP:0003040) | 2.08231802 |
| 120 | Pointed chin (HP:0000307) | 2.07192685 |
| 121 | Hemiparesis (HP:0001269) | 2.04274141 |
| 122 | Furrowed tongue (HP:0000221) | 2.03875202 |
| 123 | Clonus (HP:0002169) | 2.03098716 |
| 124 | Optic nerve hypoplasia (HP:0000609) | 2.02646993 |
| 125 | Oligodactyly (hands) (HP:0001180) | 2.02583890 |
| 126 | Fair hair (HP:0002286) | 2.02240007 |
| 127 | Status epilepticus (HP:0002133) | 2.00926722 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 2.00748765 |
| 129 | Absent speech (HP:0001344) | 2.00032474 |
| 130 | Congenital hepatic fibrosis (HP:0002612) | 1.98566546 |
| 131 | Tubular atrophy (HP:0000092) | 1.98246141 |
| 132 | Failure to thrive in infancy (HP:0001531) | 1.97643827 |
| 133 | Cupped ear (HP:0000378) | 1.97135793 |
| 134 | Lissencephaly (HP:0001339) | 1.96419564 |
| 135 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96307287 |
| 136 | Lower limb amyotrophy (HP:0007210) | 1.95496386 |
| 137 | Intention tremor (HP:0002080) | 1.94697836 |
| 138 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.94345419 |
| 139 | Cerebellar dysplasia (HP:0007033) | 1.94206388 |
| 140 | Impaired pain sensation (HP:0007328) | 1.93339773 |
| 141 | Abnormality of pain sensation (HP:0010832) | 1.93339773 |
| 142 | Ankyloglossia (HP:0010296) | 1.93306047 |
| 143 | Postaxial foot polydactyly (HP:0001830) | 1.91844108 |
| 144 | Abnormality of the 4th metacarpal (HP:0010012) | 1.89628750 |
| 145 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88949024 |
| 146 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.87971657 |
| 147 | Vitreoretinal degeneration (HP:0000655) | 1.87360298 |
| 148 | Abnormal hair whorl (HP:0010721) | 1.86120319 |
| 149 | Abnormality of saccadic eye movements (HP:0000570) | 1.85840823 |
| 150 | Sleep apnea (HP:0010535) | 1.84601250 |
| 151 | Abnormality of the labia majora (HP:0012881) | 1.84530050 |
| 152 | Ventricular fibrillation (HP:0001663) | 1.84500501 |
| 153 | Preaxial hand polydactyly (HP:0001177) | 1.83483280 |
| 154 | Amelogenesis imperfecta (HP:0000705) | 1.83336562 |
| 155 | Microtia (HP:0008551) | 1.83334255 |
| 156 | Sacral dimple (HP:0000960) | 1.82114362 |
| 157 | Incomplete penetrance (HP:0003829) | 1.82101837 |
| 158 | Generalized hypotonia (HP:0001290) | 1.81886766 |
| 159 | Medial flaring of the eyebrow (HP:0010747) | 1.81836253 |
| 160 | Generalized hypopigmentation of hair (HP:0011358) | 1.81782368 |
| 161 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.80677986 |
| 162 | Blue irides (HP:0000635) | 1.79953364 |
| 163 | Septo-optic dysplasia (HP:0100842) | 1.79827171 |
| 164 | Genital tract atresia (HP:0001827) | 1.79724213 |
| 165 | Vaginal atresia (HP:0000148) | 1.79165499 |
| 166 | Inappropriate behavior (HP:0000719) | 1.78786469 |
| 167 | Hematochezia (HP:0002573) | 1.78533728 |
| 168 | Colon cancer (HP:0003003) | 1.78511937 |
| 169 | Gait ataxia (HP:0002066) | 1.78462037 |
| 170 | Hypoplastic iliac wings (HP:0002866) | 1.78444847 |
| 171 | Increased corneal curvature (HP:0100692) | 1.78186513 |
| 172 | Keratoconus (HP:0000563) | 1.78186513 |
| 173 | Intestinal atresia (HP:0011100) | 1.75781997 |
| 174 | Occipital encephalocele (HP:0002085) | 1.75356286 |
| 175 | Long nose (HP:0003189) | 1.74104598 |
| 176 | Chorioretinal atrophy (HP:0000533) | 1.72498604 |
| 177 | Birth length less than 3rd percentile (HP:0003561) | 1.69725730 |
| 178 | Abnormality of alanine metabolism (HP:0010916) | 1.68922444 |
| 179 | Hyperalaninemia (HP:0003348) | 1.68922444 |
| 180 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68922444 |
| 181 | Preaxial foot polydactyly (HP:0001841) | 1.68810921 |
| 182 | Recurrent bacterial skin infections (HP:0005406) | 1.67721366 |
| 183 | Tracheomalacia (HP:0002779) | 1.67489081 |
| 184 | Spontaneous hematomas (HP:0007420) | 1.67114654 |
| 185 | Disproportionate short-trunk short stature (HP:0003521) | 1.66373400 |
| 186 | Aplasia of the phalanges of the hand (HP:0009802) | 1.65942632 |
| 187 | Aplasia involving bones of the extremities (HP:0009825) | 1.65942632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.74168962 |
| 2 | NTRK3 | 4.23447374 |
| 3 | EPHA4 | 4.21727679 |
| 4 | MAP3K9 | 4.11226892 |
| 5 | MARK1 | 4.06069746 |
| 6 | MAP3K4 | 3.31325172 |
| 7 | STK38L | 3.00446896 |
| 8 | LATS1 | 2.84191105 |
| 9 | MAP2K7 | 2.79199329 |
| 10 | MINK1 | 2.74829513 |
| 11 | IRAK4 | 2.44399936 |
| 12 | NTRK2 | 2.42368032 |
| 13 | KSR2 | 2.36144826 |
| 14 | ACVR1B | 2.35971210 |
| 15 | BMPR1B | 2.29092330 |
| 16 | DAPK2 | 2.27621311 |
| 17 | INSRR | 2.23799243 |
| 18 | MAP3K12 | 2.12266126 |
| 19 | IRAK1 | 2.03053472 |
| 20 | CASK | 2.02784619 |
| 21 | MAP2K4 | 1.95425570 |
| 22 | NTRK1 | 1.90380142 |
| 23 | PAK6 | 1.88980310 |
| 24 | TIE1 | 1.87057908 |
| 25 | PTK2B | 1.83648386 |
| 26 | KSR1 | 1.80723413 |
| 27 | MAPK13 | 1.67200460 |
| 28 | ADRBK2 | 1.64985808 |
| 29 | DAPK1 | 1.56021106 |
| 30 | CDK5 | 1.55359909 |
| 31 | IRAK2 | 1.54635271 |
| 32 | PINK1 | 1.54424272 |
| 33 | CAMKK1 | 1.53889559 |
| 34 | YES1 | 1.51230221 |
| 35 | TAOK1 | 1.49750616 |
| 36 | LATS2 | 1.49514710 |
| 37 | PRKD3 | 1.49403540 |
| 38 | EPHB1 | 1.48660009 |
| 39 | FGFR2 | 1.46627960 |
| 40 | WNK1 | 1.38489236 |
| 41 | ZAK | 1.37973486 |
| 42 | FES | 1.28352477 |
| 43 | PRPF4B | 1.27656605 |
| 44 | PLK2 | 1.27484996 |
| 45 | FGR | 1.26074104 |
| 46 | TNIK | 1.25114902 |
| 47 | NUAK1 | 1.24647758 |
| 48 | ARAF | 1.23967313 |
| 49 | MAP3K2 | 1.22380248 |
| 50 | PDK4 | 1.21650406 |
| 51 | PDK3 | 1.21650406 |
| 52 | TGFBR1 | 1.20108194 |
| 53 | ADRBK1 | 1.19909668 |
| 54 | PRKCG | 1.19647061 |
| 55 | NLK | 1.17794780 |
| 56 | CSK | 1.16367883 |
| 57 | NEK1 | 1.13760584 |
| 58 | SIK2 | 1.12937017 |
| 59 | BLK | 1.11483336 |
| 60 | EPHB2 | 1.09260423 |
| 61 | GRK5 | 1.07416042 |
| 62 | SGK2 | 1.07320984 |
| 63 | MET | 1.05960285 |
| 64 | BRSK2 | 1.05163006 |
| 65 | PHKG1 | 1.04923694 |
| 66 | PHKG2 | 1.04923694 |
| 67 | DYRK3 | 1.04221499 |
| 68 | STK38 | 1.03547332 |
| 69 | SGK223 | 1.03179267 |
| 70 | SGK494 | 1.03179267 |
| 71 | ERBB4 | 1.03170274 |
| 72 | STK3 | 1.02851453 |
| 73 | MAP3K13 | 1.02249484 |
| 74 | GRK1 | 1.01982311 |
| 75 | AKT3 | 0.97901707 |
| 76 | TYRO3 | 0.95686222 |
| 77 | RIPK4 | 0.94883237 |
| 78 | CDK18 | 0.93610328 |
| 79 | CAMK2A | 0.91579893 |
| 80 | CDK15 | 0.88440485 |
| 81 | NEK9 | 0.87962862 |
| 82 | EPHA3 | 0.87779994 |
| 83 | RAF1 | 0.87708270 |
| 84 | CDK14 | 0.85115153 |
| 85 | UHMK1 | 0.84473452 |
| 86 | PTK6 | 0.82991165 |
| 87 | PRKCH | 0.82657582 |
| 88 | WNK4 | 0.82575754 |
| 89 | MKNK2 | 0.81814302 |
| 90 | SGK3 | 0.79519891 |
| 91 | PAK3 | 0.78140048 |
| 92 | MAP3K7 | 0.77337032 |
| 93 | MARK2 | 0.76451722 |
| 94 | LMTK2 | 0.75074912 |
| 95 | CDK11A | 0.74882808 |
| 96 | BRAF | 0.74874786 |
| 97 | EPHA2 | 0.74148700 |
| 98 | ERBB2 | 0.73935886 |
| 99 | TAOK3 | 0.73384417 |
| 100 | MAP3K6 | 0.73248677 |
| 101 | RET | 0.70317034 |
| 102 | SGK1 | 0.68478366 |
| 103 | TEC | 0.68416069 |
| 104 | MAP2K3 | 0.67716645 |
| 105 | ALK | 0.67337147 |
| 106 | STK11 | 0.66534765 |
| 107 | HCK | 0.66434906 |
| 108 | PRKAA2 | 0.64283566 |
| 109 | RPS6KA2 | 0.62792115 |
| 110 | PIK3CG | 0.60885526 |
| 111 | BTK | 0.60388442 |
| 112 | MST1R | 0.60283102 |
| 113 | CSNK1A1L | 0.59762791 |
| 114 | MELK | 0.59345367 |
| 115 | MUSK | 0.58937768 |
| 116 | MAP4K2 | 0.58721823 |
| 117 | TNK2 | 0.58307814 |
| 118 | CSNK1G2 | 0.58249148 |
| 119 | TSSK6 | 0.57078484 |
| 120 | CDK19 | 0.56731518 |
| 121 | CCNB1 | 0.55730593 |
| 122 | CAMKK2 | 0.55035267 |
| 123 | ITK | 0.54265758 |
| 124 | SCYL2 | 0.53840242 |
| 125 | TRIM28 | 0.53452729 |
| 126 | MAP2K1 | 0.52194357 |
| 127 | RPS6KA3 | 0.51924714 |
| 128 | PDK2 | 0.51522241 |
| 129 | DYRK1A | 0.51381127 |
| 130 | CDK8 | 0.50834076 |
| 131 | CAMK2B | 0.50832183 |
| 132 | JAK3 | 0.50756753 |
| 133 | SIK3 | 0.50670276 |
| 134 | PRKCZ | 0.50515055 |
| 135 | PNCK | 0.49596733 |
| 136 | CSNK1G1 | 0.49171569 |
| 137 | PRKCE | 0.47642140 |
| 138 | CAMK1 | 0.47441044 |
| 139 | STK39 | 0.46250870 |
| 140 | DYRK2 | 0.45950676 |
| 141 | BMPR2 | 0.45470706 |
| 142 | TGFBR2 | 0.45312612 |
| 143 | PDK1 | 0.44270179 |
| 144 | TXK | 0.44136562 |
| 145 | WNK3 | 0.43831441 |
| 146 | MAPK10 | 0.42445575 |
| 147 | STK24 | 0.41851257 |
| 148 | FER | 0.41692685 |
| 149 | BCR | 0.41371589 |
| 150 | PDPK1 | 0.40223678 |
| 151 | CAMK4 | 0.39812195 |
| 152 | LYN | 0.38964353 |
| 153 | JAK2 | 0.38202368 |
| 154 | MKNK1 | 0.38191965 |
| 155 | BRSK1 | 0.37823086 |
| 156 | FYN | 0.36535350 |
| 157 | ERBB3 | 0.35530074 |
| 158 | MAP3K1 | 0.35332463 |
| 159 | PRKCB | 0.33064235 |
| 160 | ROCK1 | 0.32838851 |
| 161 | DAPK3 | 0.31955169 |
| 162 | OXSR1 | 0.30479348 |
| 163 | NEK6 | 0.28254010 |
| 164 | PRKACA | 0.27972536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.69956931 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.59877660 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.15821477 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.92450854 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70589687 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.70574224 |
| 7 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.63290299 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.62809538 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48508408 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38692761 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.35826512 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31016528 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.22797652 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.17605811 |
| 15 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.12705030 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.05579362 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.00343215 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.96735723 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.88334369 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84868511 |
| 21 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.82165990 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79379418 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.78273466 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.77331035 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.69406863 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.69334975 |
| 27 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.68960587 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62831642 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62753918 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.60137019 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.59029142 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57438059 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48298327 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44143777 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.43338588 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42123343 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41587705 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.37613442 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33563237 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31197730 |
| 41 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27653870 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26952385 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.24660359 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.23172059 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.22391856 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22061557 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.21851814 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.21720055 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13620095 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 1.12872778 |
| 51 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.12769945 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12543713 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12429328 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11255294 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08695797 |
| 56 | Glioma_Homo sapiens_hsa05214 | 1.07007184 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04901983 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04724942 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03788929 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03707318 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03397130 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03051769 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02822874 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00796534 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00598203 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.99687858 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.98024145 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97388895 |
| 69 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.97153333 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95981721 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93193294 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90672200 |
| 73 | Melanogenesis_Homo sapiens_hsa04916 | 0.89567680 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89073288 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87643941 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87452301 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.85279131 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.85005718 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84635610 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81958391 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80416945 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79296485 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76859363 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.76420070 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.74296343 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74045662 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73601681 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73526805 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73313987 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.72005548 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71507056 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70227155 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69320088 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69033906 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68387318 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68146115 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.67466362 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65931662 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65854366 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65320481 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64832739 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64651787 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64449348 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63531217 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62832752 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.62200371 |
| 107 | Adherens junction_Homo sapiens_hsa04520 | 0.60591613 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.60457616 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59084101 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59077594 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58108323 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58022671 |
| 113 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56478113 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56279817 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56090904 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55244220 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54122792 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53946350 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53343076 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53034211 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51529663 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50330373 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50197698 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49952451 |
| 125 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49737790 |
| 126 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49727473 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48865453 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48067242 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47964337 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46806644 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46539149 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46392039 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46122275 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45433401 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44568258 |
| 136 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43416934 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42227798 |
| 138 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40904735 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40191329 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.39350880 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.39001458 |
| 142 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38455081 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37915888 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37697574 |
| 145 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37404759 |
| 146 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.37071467 |
| 147 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36339460 |
| 148 | Bile secretion_Homo sapiens_hsa04976 | 0.36146081 |
| 149 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32409901 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31639046 |
| 151 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30353776 |
| 152 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29944662 |
| 153 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.28994186 |
| 154 | Parkinsons disease_Homo sapiens_hsa05012 | 0.28679369 |
| 155 | Tight junction_Homo sapiens_hsa04530 | 0.28272862 |
| 156 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27556636 |

